|
|
||||||||
Department of Basic Medical Sciences, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
| Abstract |
|---|
|
|
|---|
100, as a [PSI+]-eliminating factor in S. cerevisiae. Rnq1
100 deletes the N-terminal non-prion domain of Rnq1, and eliminates [PSI+] in [PIN+] yeast. Here we found that [PIN+] is transmissible to Rnq1
100 in the absence of full-length Rnq1, forming a novel prion variant [RNQ1
100+]. [RNQ1
100+] has similar [PIN+] properties as it stimulates the de novo induction of [PSI+] and is eliminated by the null hsp104
mutation, but not by Hsp104 overproduction. In contrast, [RNQ1
100+] inherits the inhibitory activity and hampers the maintenance of [PSI+] though less efficiently than [PIN+] made of Rnq1–Rnq1
100 co-aggregates. Interestingly, [RNQ1
100+] prion was eliminated by de novo [PSI+] induction. Thus, the [RNQ1
100+] prion demonstrates selfish activity to eliminate a heterologous prion in S. cerevisiae, showing the first instance of a selfish prion variant in living organisms. | Introduction |
|---|
|
|
|---|
This problem has been approached in many studies of the [PSI+] determinant (Cox 1965), which is the prion form (Ter-Avanesyan et al. 1994; Wickner 1994; Zhouravleva et al. 1995; Paushkin et al. 1996) of the polypeptide release factor Sup35 (eRF3) that is essential for terminating protein synthesis at stop codons (Stansfield et al. 1995; Zhouravleva et al. 1995; for a review see Ehrenberg et al. 2007). When Sup35 is in the [PSI+] state, ribosomes often fail to release polypeptides at stop codons, causing a non Mendelian trait easily detected by nonsense suppression (Liebman & Sherman 1979; Patino et al. 1996; Paushkin et al. 1996). Auxotrophic markers ade1-14 or ade2-1 (nonsense mutations) have been widely used to select for and study [PSI+] since the nonsense suppression by [PSI+] is easily selected for on synthetic medium lacking adenine and also prevents the build-up of adenine metabolites that would cause [psi–] cells (soluble Sup35, no nonsense suppression) to turn red on rich media.
In contrast to the ade1- or ade2-based approach to the [PSI+] state, the chromosomal ura3–197 (non-sense) allele provided us with a powerful tool to select for the [psi–] state (i.e. loss-of-[PSI+]), in which yeast cells become viable in the presence of 5-fluoroorotic acid (5-FOA) at concentrations otherwise toxic to [PSI+] cells (Kurahashi & Nakamura 2007; Kurahashi et al. 2008). Using this tool, we have isolated a prion inhibitor, Rnq1
100, that eliminates [PSI+] when overproduced (Kurahashi et al. 2008). Rnq1 is a protein of unknown function and is one of several known yeast proteins containing a QN-rich prion domain, hence named so for rich in asparagine (N) and glutamine (Q) (Sondheimer & Lindquist 2000). Rnq1
100 deletes the N-terminal non-prion domain of Rnq1, and inhibits the maintenance of not only [PSI+] but also [URE3] and Huntingtin's polyglutamine (polyQ) aggregate in a [PIN+] background, but not in a [pin–] background. Rnq1
100, however, does not eliminate [PIN+]. These findings are interpreted to indicate that Rnq1–Rnq1
100 co-aggregates in the [PIN+] state interact with other transmissible and non-transmissible amyloids to destabilize and lose their amyloid form.
To gain further insight into the nature of Rnq1
100, we investigated whether or not the [PIN+] state of Rnq1 can be transmissible to Rnq1
100 in the absence of full-length Rnq1, and whether Rnq1
100 alone is sufficient to propagate the transmitted prion state, despite of its inhibitor activity. In this study, we found that [PIN+] is transmissible to Rnq1
100 when expressed from a strong promoter, but not from a weak promoter, and the resulting prion form of Rnq1
100, newly designated [RNQ1
100+], demonstrates selfishness towards other heterologous prion(s).
| Results |
|---|
|
|
|---|
100
Rnq1
100 deletes the N-terminal non-QN rich domain of Rnq1, and is thereby highly QN-rich and prone to self-aggregate or co-aggregate with Rnq1 (Kurahashi et al. 2008). Previously, we reported that in [PIN+] cells, Rnq1
100 is incorporated into the [PIN+] aggregates of Rnq1, thereby producing a prion-like co-aggregate (Kurahashi et al. 2008). In this study, we examined the ability of Rnq1
100 alone to form a prion in the absence of full-length Rnq1 by constructing several S. cerevisiae strains (the flowchart of strain manipulations is shown in Fig. 1A). Two sets of plasmids (HIS3 marker) expressing Rnq1
100 and full-length Rnq1 (control) from a strong (ADH) or a weak (CYC1) promoter were manipulated (note that plasmids are designated with both the promoter and the Rnq1 form, such as pADHp–rnq1
100 or pCYC1p–RNQ1) (Mumberg et al. 1995), and transformed into the [PIN+]
RNQ1 strain (NPK200). As expected, all the transformants were [PIN+] (Kurahashi et al. 2008), and their chromosomal RNQ1 gene was subsequently knocked out by transformation with the rnq1
(i.e. rnq1 :: URA3) sequence as described previously (Kurahashi et al. 2008; see Experimental procedures). In parallel, [pin–] variants (control) from each strain were made by nullifying the chromosomal RNQ1 of NPK200 with rnq1
, followed by transformation with Rnq1
100 or Rnq1 expression plasmids. Notably, the abundance of Rnq1 synthesized from plasmid pCYC1p–RNQ1 is similar to that from the native chromosome (shown in Fig. 1B, compare NPK494 and NPK521 for [PIN+], or NPK525 and NPK520 for [pin–]), and thereby is useful to interpret the prion-forming ability in wild-type yeast.
|
100 proteins synthesized in these transformants were analyzed by Western blotting using anti-Rnq1 antibody. Of these, note the two strains NPK488 and NPK496, which are chromosomally rnq1
and instead express Rnq1
100 from the ADH and CYC1 promoters, respectively. As shown in Fig. 1B, Rnq1 is not synthesized in both strains and, in turn, Rnq1
100 is abundant in NPK488, but not in NPK496. The failure of Rnq1
100 detection in NPK496 might be due to the weakness of the CYC1 promoter and/or possibly the protein's instability in the [pin–] state (see below). Similarly, reduced levels of Rnq1
100 are also evident in NPK526, in which Rnq1
100 is expressed from the CYC1 promoter in the [pin–] state (Fig. 1B). Taking the later findings into consideration, it seems very likely that Rnq1 and Rnq1
100 are more abundant in [PIN+] cells than in the isogenic [pin–] cells (Fig. 1B), presumably reflecting an increased stability of both proteins in prion aggregates. [Note that the low abundance of Rnq1
100 in [pin–] cell lysates did not change in the presence of the protease inhibitor NEM (data not shown).] A few extra bands appearing from NPK523 may indicate degradation products of Rnq1; marked with asterisks in Fig. 1B.
Next, we examined the [PIN+] state by monitoring Rnq1 or Rnq1
100 aggregates using semi-denaturing detergent-agarose gel electrophoresis in the presence of 1% SDS (SDD-AGE; Kryndushkin et al. 2003; Liebman et al. 2006). Western blot analysis indicated that SDS-stable polymers are formed in NPK486, NPK488, and NPK494, but not in NPK496 or the other strains tested (Fig. 1C). These findings indicated that [PIN+] is transmissible to Rnq1
100 expressed from the strong ADH promoter, but not to Rnq1
100 expressed from the weak CYC1 promoter. Again, Rnq1
100 expressed from the weak CYC1 promoter was undetectable in NPK496 and NPK526 (Fig. 1C).
Further, we examined the [PIN+] state by monitoring Rnq1 or Rnq1
100 aggregates using a fusion of Rnq1 and green fluorescent protein (Rnq1–GFP) expressed from the CUP1 promoter in the presence of CuSO4. Rnq1–GFP formed punctate foci in NPK486, NPK488, and NPK494, whereas it showed mostly cytoplasmic, dispersed fluorescence (i.e., [pin–]) in NPK496 and the other strains tested (note that the appearance of a few aggregates in [pin–] cells is probably due to the overproduction of Rnq1 protein and the tendency of Rnq1
100 to self-aggregate), with the exception of NPK521 ([PIN+] control) (Fig. 1D). These results confirm that the [PIN+] state is transmissible to Rnq1
100 expressed from the ADH promoter, not from the CYC1 promoter, in the absence of full-length Rnq1. The putative prion form of Rnq1
100 transmitted from the [PIN+] state of Rnq1 is tentatively referred to as [RNQ1
100+] since it shows shared as well as distinct properties compared to [PIN+] (see below).
Genetic evidence for [RNQ1
100+] prion
The non-Mendelian inheritance of [RNQ1
100+] was examined by tetrad analysis of [RNQ1
100+]/[rnq1
100–] heterozygous diploid made by crossing the [RNQ1
100+] strain (NPK488 carrying the HIS3-marked Rnq1
100 plasmid) with the [rnq1
100–] strain (NPK576 carrying the TRP1-marked Rnq1
100 plasmid). The control [rnq1
100–]/[rnq1
100–] homozygous diploid was also made by crossing NPK576 with the [rnq1
100–] strain (NPK524 carrying the HIS3-marked Rnq1
100 plasmid). The flowchart of strain manipulations is shown in Fig. 2A. After sporulation of these diploids, two asci each were examined by SDD-AGE analysis. As shown in Fig. 2B, the [RNQ1
100+]/[rnq1
100–] heterozygous diploid contained SDS-stable Rnq1
100 polymers, representing the [RNQ1
100+] prion. Of eight spores derived from [RNQ1
100+]/[rnq1
100–] diploid, one spore (B-4) lost both HIS3- and TRP1-marked Rnq1
100 plasmids, thus showing the [pin–] state, while the other spores contained either plasmid or both, thus showing the [RNQ1
100+] state. The [RNQ1
100+] state was also confirmed by the fluorescence study (as above) using Rnq1–GFP (data not shown) as well as by the Pin assay (Fig. 2C and see below). Spores derived from the control [rnq1
100–]/[rnq1
100–] homozygous diploid were essentially [rnq1
100–], while the one spore (D-2) contained SDS-stable Rnq1
100 polymers, though less abundant. Further study using Rnq1–GFP, however, detects a diffused fluorescence with some foci in the D-2 spore as found in [rnq1
100–] (data not shown), suggesting that the observed polymers in D-2 does not represent the [RNQ1
100+] prion but a non-prion aggregate formed by overexpression.
|
100+] prion is transmissible to the full-length Rnq1. The [pin–] strain NPK569 (MAT
, wild-type RNQ1 TRP1) was crossed with the [RNQ1
100+] strain NPK488 (MATa, rnq1
, carrying the HIS3-marked Rnq1
100 plasmid), and the resulting heterozygous diploid was selected first on SC–his–trp plates, and then grown in SC+his–trp medium. The plasmid segregants that no longer synthesize Rnq1
100 were isolated and examined for the Rnq1-prion state by the fluorescence study using Rnq1–GFP and the Pin assay. Of 10 such segregants tested, nine were in the Rnq1-prion state, while one in the non-prion state (data not shown). Although the precise nature of Rnq1 prion transmitted from [RNQ1
100+] remains to be characterized, the data clearly showed that [RNQ1
100+] is transmissible to the full-length Rnq1.
Pin+ phenotype transmitted to [RNQ1
100+] prion
The most remarkable phenotype of the [PIN+] prion is an increase in the de novo induction of [PSI+], hence referred to as Pin+ (Derkatch et al. 1997). To examine whether the Pin+ phenotype is associated with [RNQ1
100+] or not, all strains constructed above were transformed with plasmid pCUP1p-NM, a pRS414 (TRP1)-based plasmid over-expressing Sup35's NM prion domain from the CUP1 promoter (Kurahashi et al. 2008). Transformants were grown in SC–trp–his liquid medium supplemented with 50 µM CuSO4 for 2 days (about 48 h), subsequently spotted on YPD and SC-ade plates in fivefold serial dilutions, and then grown for 3 days on YPD or 7 days on SC-ade or SC-ade-his (to secure the presence of HIS3-marked plasmid pADHp-rnq1
100). As shown in Fig. 3, NPK486, NPK488, and NPK494, but not NPK496, showed increased de novo induction of [PSI+] prion, indicating that the Pin+ phenotype is successfully transmitted from Rnq1 to the [RNQ1
100+] prion. It is noteworthy that the induction frequency is similar between [RNQ1
100+] and [PIN+] made of full-length Rnq1 (see Fig. 3B). Interestingly, Ade+ colonies borne from NPK488 lost the original [RNQ1
100+] prion (described shortly).
|
mutation but not by Hsp104 overproduction (Derkatch et al. 1997; Sondheimer & Lindquist 2000). Hsp104 is a member of the ClpB family of AAA+ proteins (ATPases associated with various cellular activities; Ogura & Wilkinson 2001), and is required for the propagation of [PSI+], [URE3], and [PIN+] prions since it breaks up amyloid filaments to generate prion seeds for efficient prion transmission (Paushkin et al. 1996; Jung et al. 2002; Ness et al. 2002). To examine the effect of Hsp104 on [RNQ1
100+]-prion polymers, Hsp104 was either nullified (chromosomal substitution of hsp104
) or overexpressed (plasmid pGPDp-HSP104) in three PIN strains; NPK486, NPK488, and NPK521 (control strain) (see Experimental procedures). The SDD-AGE analysis clearly indicated that [RNQ1
100+]-prion polymers were eliminated by hsp104
, but unaffected by pGPDp–HSP104 (Fig. 4A,B). The same results were confirmed by the fluorescence study (as above) using Rnq1–GFP (data not shown).
|
(Fig. 4C), and the increased synthesis of Hsp104 by pGPDp–HSP104 (Fig. 4E; also note that Fig. 4D represents the Western blot of Hsp104 synthesized in pGPDp-HSP104 segregants). Also, under these conditions, the abundance of Rnq1 or Rnq1
100 remained either unchanged or slightly reduced in hsp104
strains (Fig. 4C,D). These results indicate that the [RNQ1
100+] prion shares the same sensitivity to Hsp104 as [PIN+].
Inhibitory action of [RNQ1
100+] on [PSI+]
Finally we examined whether [RNQ1
100+] exerts the same inhibitory action on [PSI+] as Rnq1
100 in the [PIN+] state. For this purpose, the NPK488 strain ([RNQ1
100+], [psi–]) and its non-prion (control) strain NPK524 ([rnq1
100–] or [pin–], [psi–]) were mated to different [PSI+] strains containing [pin–], rnq1
allele (NPK527); [pin–], RNQ1 allele (NPK519) or [PIN+], RNQ1 allele (NPK550). The resulting diploids were scored for their [PSI+] phenotype by the ade1–14 (nonsense)-based colony color on YPD plates. Most importantly, the [pin-]
rnq1
/[RNQ1
100+] rnq1
100 heterozygous diploid (NPK527 x NPK488), containing only Rnq1
100, produced both red and white colonies, while the isogenic [pin–]
rnq1
/[rnq1
100–]
rnq1
100 heterozygous diploid (NPK527 x NPK524) never produced red colonies (Fig. 5). Notably, the frequency of red colonies, that is, [PSI+] elimination, from the [pin–]
rnq1
/[RNQ1
100+] rnq1
100 diploid (NPK527 x NPK488) is significantly lower than that from [PIN+] RNQ1/[RNQ1
100+]
rnq1
100 heterozygous diploid (NPK550 x NPK488), in which Rnq1
100 is rather incorporated into [PIN+] Rnq1-aggregates giving rise to strong [PSI+] elimination, as shown previously (Kurahashi et al. 2008) (Fig. 5). The low frequency of [PSI+] elimination was not reversed in the [pin–]
RNQ1/[RNQ1
100+]
rnq1
100 heterozygous diploid (NPK519 x NPK488) (Fig. 5). These findings are interpreted to indicate that the [RNQ1
100+] prion inhibits the maintenance of [PSI+], but less efficiently compared to [PIN+] made of Rnq1–Rnq1
100 co-aggregates. Importantly, the white colonies retaining [PSI+] lost [RNQ1
100+] (5/5) when monitored by SDD-AGE and Rnq1–GFP foci analyses (data not shown), suggesting that [PSI+] and [RNQ1
100+] are incompatible.
|
100+] prion state upon [PSI+] induction
The above finding raises the question of why [PSI+] cells induced de novo by [RNQ1
100+] (in Fig. 3) could be propagated, and not inhibited by [RNQ1
100+]. Since these [PSI+] colonies were generated on SC-ade plates depleted of histidine, which is a selection marker of the Rnq1
100-maintainer plasmid pADHp–rnq1
100 (see Fig. 3), the apparent lack of inhibition is not due to a segregation of pADHp–rnq1
100. The presence of [PSI+] in Ade+ colonies appeared from NPK488 was first confirmed in the absence of plasmid pCUP1p-NM (Fig. 6B), as well as by the prion-curing experiment using guanidine hydrochloride (Fig. 6C). Then, we checked the [RNQ1
100+] prion state in de novo induced [PSI+] cells. Three independent [PSI+] colonies induced in NPK488 were isolated and their cell lysates were examined by SDD-AGE. Immunoblotting by anti-Rnq1 antibody revealed that Rnq1
100 no longer forms a polymer but rather remains as a monomer (Fig. 6D; the weakness in the intensity of NPK521 compared with the other strains is due to the weak expression of Rnq1 from the native promoter). The same results were confirmed by the fluorescent study using Rnq1–GFP (data not shown).
|
100+] prion is genetically unstable and lost during the [PSI+]-inducing process. To test this possibility, the same NM-overexpressed cells were spotted on SC-his instead of SC-ade-his, and His+ colonies (containing pADHp–rnq1
100) were selected unbiasedly, and re-grown on YPD plates. These formed mostly red ([psi–]) colonies and a few white ([PSI+]) colonies. After confirming loss of pCUP1p–NM, the resulting red colonies were examined for their [RNQ1
100+] prion state by SDD-AGE and Rnq1–GFP foci analyses. The data showed that these [psi–] cells isolated through essentially the same selection procedure as for [PSI+] were [RNQ1
100+] (4/4) (data not shown), revealing that [RNQ1
100+] is not genetically unstable. These findings indicate that the [RNQ1
100+] prion state was lost upon induction of [PSI+] prion. | Discussion |
|---|
|
|
|---|
100, can be incorporated into the preexisting [PIN+] aggregate of Rnq1 and inhibits the maintenance of other prions, [PSI+] and [URE3], as well as toxic polyQ aggregates (Kurahashi et al. 2008). These findings were interpreted to indicate that Rnq1–Rnq1
100 co-aggregates in [PIN+] state interact with other transmissible and non-transmissible amyloids to destabilize and lose their amyloid form. These results raised a question of whether Rnq1
100 alone forms a prion or not. In this study, we found that the [PIN+] prion can be transmissible to Rnq1
100 in the absence of the full-length Rnq1 protein, but only when overproduced by the strong ADH promoter, and not by the weak CYC1 promoter. Therefore, abundant expression of Rnq1
100 is a prerequisite for transmission from [PIN+]. The resulting prion form of Rnq1
100, designated [RNQ1
100+], shares the same properties as the [PIN+] prion of full-length Rnq1 as it stimulates the de novo induction of [PSI+], and is eliminated by the null hsp104
mutation but not by Hsp104 overproduction. However, unlike [PIN+], [RNQ1
100+] hampers the maintenance of [PSI+] as does Rnq1–Rnq1
100 co-aggregates in the [PIN+] state. Therefore, Rnq1
100 forms a selfish prion that excludes other prions and amyloid aggregates. To our knowledge, this is the first instance of a selfish prion variant in living organisms.
Rnq1's C-terminal is highly QN-rich. We suggest that upon removal of the non-QN rich (non-prion) domain of Rnq1, Rnq1
100 gains a strong tendency to interact with other QN-rich proteins. Thus, the [RNQ1
100+] prion aggregate might bind to the growing tip of a heterologous prion aggregate including [PSI+] and [URE3], and block its rapid growth, leading to its destabilization and loss. It was apparently controversial that [RNQ1
100+] stimulates the de novo induction of [PSI+] but hampers the maintenance of existing [PSI+]. This inconsistency was solved by the finding that [PSI+] and [RNQ1
100+] prions are incompatible each other and upon induction of [PSI+] by [RNQ1
100+]-mediated Pin action, [RNQ1
100+] is eliminated. The molecular basis of this sacrificial cross-seeding of prion propagation remains to be investigated. Moreover, it is of interest to investigate whether or not the selfish prion nature of [RNQ1
100+] can be cross transmitted to newly-induced [PSI+] prions.
| Experimental procedures |
|---|
|
|
|---|
The original strains used in this study are: NPK200 ([psi–]
[PIN+]
MATa ade1–14 leu2 ura3 his3 trp1), NPK51 ([psi–]
[pin–]
MATa ade1–14 leu2 ura3 his3 trp1), NPK519 ([PSI+]
[pin–]
MAT
ade1–14 leu2 ura3 his3), NPK527 (rnq1 :: URA3 derivative of NPK519), NPK550 ([PIN+] derivative of NPK519, see Kurahashi et al. 2008), NPK569 ([psi–]
[pin–]
MAT
ade1–14 leu2 ura3 his3), and NPK576 ([psi–]
[rnq1
100–]
MAT
ade1–14 leu2 ura3 his3 trp1 rnq1 :: URA3 [pADHp-rnq1
100 (TRP1 marker)]). The other strains derived from these are described in Fig. 1A. Whole deletions of HSP104 (hsp104 :: LEU2) or RNQ1 (rnq1 :: URA3) were performed as described previously (Kurahashi & Nakamura 2007; Kurahashi et al. 2008). Media and other manipulations including transformation, tetrad analysis and fluorescence microscopy are as described previously (Kurahashi & Nakamura 2007; Kurahashi et al. 2008).
Plasmids
Plasmids used are pRS400 series vectors (Stratagene) and their expression derivatives (designated by the promoter, such as pADHp, pCYC1p, pGPDp, or pCUP1p) containing the ADH, CYC1, GPD, or CUP1 promoter and the CYC1 terminator for expression of exogenous sequences (Mumberg et al. 1995; Kurahashi et al. 2008). pADHp–RNQ1, pADHp–rnq1
100, pCYC1p–RNQ1, or pCYC1p–rnq1
100 were constructed by cloning BamHI–XhoI fragments of RNQ1 or rnq1
100 (Kurahashi et al. 2008) into the BamHI–XhoI site of pADHp (ARS/CEN, HIS3 or TRP1 marker) or pCYC1p (ARS/CEN, HIS3 marker). The Hsp104-expression plasmid pGPDp-HSP104 is descried previously (Ishiwata et al. 2009). The Rnq1–GFP and Sup35 NM domain expression plasmid, pCUP1p–Rnq1–GFP (ARS/CEN, TRP1, or LEU2 marker) and pCUP1p–NM (ARS/CEN, TRP1, or LEU2 marker) are described previously (Kurahashi et al. 2008).
Induction of [PSI+] element
[PSI+] was induced in [psi–] cells upon transformation with pCUP1p–NM (TRP1 or LEU2 marker). Transformants were grown in SC medium lacking selective nutrients and supplemented with 50 µM CuSO4 for 2 or 3 days and were subsequently spotted on SC-ade, SC-ade-his and YPD plates (for control), and then grown for 7 days on SC-ade and SC-ade-his, or for 3 days on YPD.
Protein analysis
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and SDD-AGE were carried out as described previously (Kurahashi & Nakamura 2007). The immunoblot experiments were performed using anti-Rnq1 antibody (Kurahashi & Nakamura 2007), anti-Hsp104 antibody (Affinity Bioreagents) and anti-Pgk1 antibody (Molecular Probes).
| Acknowledgements |
|---|
| Footnotes |
|---|
* Correspondence: nak{at}ims.u-tokyo.ac.jp
| References |
|---|
|
|
|---|
Cox, B.S. (1965)
, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 20, 505–521.[CrossRef]
Derkatch, I.L., Bradley, M.E., Zhou, P., Chernoff, Y.O. & Liebman, S.W. (1997) Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147, 507–519.[Abstract]
Ehrenberg, M., Hauryliuk, V., Crist, C.G. & Nakamura, Y. (2007) Translation termination, prion [PSI+], and ribosome recycling. In: Translational Control in Biology and Medicine (eds M.B. Mathews, N. Sonenberg & J.W.B. Hershey), pp. 173–196. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
Ishiwata, M., Kurahashi, H. & Nakamura, Y. (2009) A G-protein
subunit mimic is a general antagonist of prion propagation in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 106, 791–796.
Jung, G., Jones, G. & Masison, D.C. (2002) Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc. Natl. Acad. Sci. USA 99, 9936–9941.
Kryndushkin, D.S., Alexandrov, I.M., Ter-Avanesyan, M.D. & Kushnirov, V.V. (2003) Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 278, 49636–49643.
Kurahashi, H., Ishiwata, M., Shibata, S. & Nakamura, Y. (2008) A regulatory role of the Rnq1 non-prion domain for prion propagation and polyglutamine aggregates. Mol. Cell. Biol. 28, 3313–3323.
Kurahashi, H. & Nakamura, Y. (2007) Channel mutations in Hsp104 hexamer distinctively affect thermotolerance and prion-specific propagation. Mol. Microbiol. 63, 1669–1683.[CrossRef][Medline]
Liebman, S.W., Bagriantsev, S.N. & Derkatch, I.L. (2006) Biochemical and genetic methods for characterization of [PSI+] prions in yeast. Methods 39, 23–34.[CrossRef][Medline]
Liebman, S.W. & Sherman, F. (1979) Extrachromosomal
+determinant suppresses nonsense mutations in yeast. J. Bacteriol. 139, 1068–1071.
Mumberg, D., Muller, R. & Funk, M. (1995) Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156, 119–122.[CrossRef][Medline]
Ness, F., Ferreira, P., Cox, B.S. & Tuite, M.F. (2002) Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol. Cell. Biol. 22, 5593–5605.
Ogura, T. & Wilkinson, A.J. (2001) AAA + superfamily ATPases: common structure-diverse function. Genes Cells 6, 575–597.[Abstract]
Patino, M.M., Liu, J.J., Glover, J.R. & Lindquist, S. (1996) Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622–626.[Abstract]
Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N. & Ter-Avanesyan, M.D. (1996) Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15, 3127–3134.[Medline]
Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144.
Prusiner, S.B. (2001) Shattuck lecture-neurodegenerative diseases and prions. N. Engl. J. Med. 344, 1516–1526.
Prusiner, S.B. (2004) Early evidence that a protease-resistant protein is an active component of the infectious prion. Cell 116, S109, 101 p following S113.[CrossRef][Medline]
Sondheimer, N. & Lindquist, S. (2000) Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell. 5, 163–172.[CrossRef][Medline]
Stansfield, I., Jones, K.M., Kushnirov, V.V., Dagkesamanskaya, A.R., Poznyakovski, A.I., Paushkin, S.V., Nierras, C.R., Cox, B.S., Ter-Avanesyan, M.D. & Tuite, M.F. (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J. 14, 4365–4373.[Medline]
Ter-Avanesyan, M.D., Dagkesamanskaya, A.R., Kushnirov, V.V. & Smirnov, V.N. (1994) The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137, 671–676.[Abstract]
Wickner, R.B. (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566–569.
Zhouravleva, G., Frolova, L., Le Goff, X., Le Guellec, R., Inge-Vechtomov, S., Kisselev, L. & Philippe, M. (1995) Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J. 14, 4065–4072[Medline]
Received: 25 September 2008
Accepted: 25 February 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |